Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma

Abstract

The expression of PINX1, a possible telomerase inhibitor and a putative tumor suppressor, has not been studied in human cancers, including gastric cancer (GC). We examined expression of PINX1 by quantitative reverse transcription (RT)–PCR in 73 cases of GC, and 45 of these cases were further studied for loss of heterozygosity (LOH) by PCR with microsatellite marker D8S277. Reduced expression (tumor vs normal ratio<0.5) of PINX1 was detected in 50 (68.5%) of 73 cases of GC. GC tissues with reduced expression of PINX1 showed significantly higher telomerase activities as measured by telomeric repeat amplification protocol than those with normal expression of PINX1 (P = 0.031). LOH of PINX1 locus was detected in 15 (33.3%) of 45 cases of GC and was correlated significantly with reduced expression of PINX1 (P=0.031). Expression of PINX1 in a GC cell line, MKN-74, was induced by treatment with trichostatin A (TSA) or nicotinamide (NAM). Chromatin immunoprecipitation assay of MKN-74 cells revealed that acetylation of histone H4 in the 5′ untranslated region (UTR) of PINX1 was enhanced by treatment with TSA or NAM, whereas acetylation of histone H3 was not changed by TSA or NAM. In addition, TSA or NAM treatment led to inhibition of telomerase activity in MKN-74 cells. These results indicate that LOH of PINX1 locus and hypoacetylation of histone H4 in the 5′ UTR of PINX1 are associated with reduced expression of PINX1 in GC.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Akiyama Y, Maesawa C, Wada K, Fujisawa K, Itabashi T, Noda Y, Honda T, Sato N, Ishida K, Takagane A, Saito K and Masuda T . (2004). Oncol. Rep., 11, 871–874.

  • Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L and DePinho RA . (2000). Nature, 406, 641–645.

    Article  CAS  Google Scholar 

  • Baffa R, Santoro R, Bullrich F, Mandes B, Ishii H and Croce CM . (2000). Clin. Cancer Res., 6, 1372–1377.

  • Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M and Sinclair DA . (2002). J. Biol. Chem., 277, 45099–45107.

    Article  CAS  Google Scholar 

  • Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, Greider CW and DePinho RA . (1999). Cell, 97, 527–538.

    Article  CAS  Google Scholar 

  • Cong YS, Wright WE and Shay JW . (2002). Microbiol. Mol. Biol. Rev., 66, 407–425.

  • DePinho RA . (2000). Nature, 408, 248–254.

    Article  CAS  Google Scholar 

  • Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M and Nakamura Y . (1992). Cancer Res., 52, 5368–5372.

  • Ferreira R, Naguibneva I, Mathieu M, Ait-Si-Ali S, Robin P, Pritchard LL and Harel-Bellan A . (2001). EMBO Rep., 2, 794–799.

  • Fujiwara Y, Emi M, Ohata H, Kato Y, Nakajima T, Mori T and Nakamura Y . (1993). Cancer Res., 53, 1172–1174.

  • Grunstein M . (1997). Nature, 389, 349–352.

    Article  CAS  Google Scholar 

  • Hamai Y, Oue N, Mitani Y, Nakayama H, Ito R, Matsusaki K, Yoshida K, Toge T and Yasui W . (2003). Cancer Sci., 94, 692–698.

  • Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB . (1996). Proc. Natl. Acad. Sci. USA, 93, 9821–9826.

  • Imai S, Armstrong CM, Kaeberlein M and Guarente L . (2000). Nature, 403, 795–800.

    Article  CAS  Google Scholar 

  • Jones PA and Baylin SB . (2002). Nat. Rev. Genet., 3, 415–428.

  • Kass SU, Pruss D and Wolffe AP . (1997). Trends Genet., 13, 444–449.

  • Kondo T, Oue N, Yoshida K, Mitani Y, Naka K, Nakayama H and Yasui W . (2004). Cancer Res., 64, 523–529.

    Article  CAS  Google Scholar 

  • Kuniyasu H, Domen T, Hamamoto T, Yokozaki H, Yasui W, Tahara H and Tahara E . (1997). Jpn. J. Cancer Res., 88, 103–107.

  • Landry J, Sutton A, Tafrov ST, Heller RC, Stebbins J, Pillus L and Sternglanz R . (2000). Proc. Natl. Acad. Sci. USA, 97, 5807–5811.

  • Lauren P . (1965). Acta. Pathol. Microbiol. Scand., 64, 31–49.

  • Liao C, Zhao M, Song H, Uchida K, Yokoyama KK and Li T . (2000). Hepatology, 32, 721–727.

    Article  CAS  Google Scholar 

  • Liao C, Zhao MJ, Zhao J, Jia D, Song H and Li ZP . (2002). World J. Gastroentrol., 8, 1050–1052.

  • Liao C, Zhao MJ, Zhao J, Song H, Pineau P, Marchio A, Dejean A, Tiollais P, Wang HY and Li TP . (2003). World J. Gastroentrol., 9, 89–93.

  • Liloglou T, Maloney P, Xinarianos G, Fear S and Field JK . (2000). Int. J. Oncol., 16, 5–14.

  • Liloglou T, Maloney P, Xinarianos G, Hulbert M, Walshaw MJ, Gosney JR, Turnbull L and Field JK . (2001). Cancer Res., 61, 1624–1628.

  • Luger K, Mader AW, Richmond RK, Sargent DF and Richmond TJ . (1997). Nature, 389, 251–260.

    Article  CAS  Google Scholar 

  • Luger K and Richmond TJ . (1998). Curr. Opin. Genet. Dev., 8, 140–146.

  • Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L and Gu W . (2001). Cell, 107, 137–148.

    Article  CAS  Google Scholar 

  • Macoska JA, Trybus TM, Benson PD, Sakr WA, Grignon DJ, Wojno KD, Pietruk T and Powell IJ . (1995). Cancer Res., 55, 5390–5395.

  • Meeker AK, Hicks JL, Platz EA, March GE, Bennett CJ, Delannoy MJ and De Marzo AM . (2002). Cancer Res., 62, 6405–6409.

  • North BJ, Marshall BL, Borra MT, Denu JM and Verdin E . (2003). Mol. Cell, 11, 437–444.

  • Ochiai A, Yasui W and Tahara E . (1985). Jpn. J. Cancer Res., 76, 1064–1071.

  • Ohata H, Emi M, Fujiwara Y, Higashino K, Nakagawa K, Futagami R, Tsuchiya E and Nakamura Y . (1993). Genes Chromosomes Cancer, 7, 85–88.

  • Oshimo Y, Oue N, Mitani Y, Nakayama H, Kitadai Y, Yoshida K, Chayama K and Yasui W . (2004). Int. J. Cancer, 110, 212–218.

    Article  CAS  Google Scholar 

  • O’Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen WT, Emerson S, Emond MJ, Gollahon KA, Moskovitz AH, Crispin DA, Potter JD and Rabinovitch PS . (2002). Nat. Genet., 32, 280–284.

  • Oue N, Hamai Y, Mitani Y, Matsumura S, Oshimo Y, Aung PP, Kuraoka K, Nakayama H and Yasui W . (2004). Cancer Res., 64, 2397–2405.

    Article  CAS  Google Scholar 

  • Oue N, Matsumura S, Nakayama H, Kitadai Y, Taniyama K, Matsusaki K and Yasui W . (2003). Oncology, 64, 423–429.

    Article  CAS  Google Scholar 

  • Oue N, Motoshita J, Yokosaki H, Hayashi K, Tahara E, Taniyama K, Matsusaki K and Yasui W . (2002). J. Pathol., 198, 55–59.

    Article  CAS  Google Scholar 

  • Oue N, Shigeishi H, Kuniyasu H, Yokosaki H, Kuraoka K, Ito R and Yasui W . (2001). Int. J. Cancer, 93, 805–809.

    Article  CAS  Google Scholar 

  • Park WS, Lee JH, Park JY, Jeong SW, Shin MS, Kim HS, Lee SK, Lee SN, Lee SH, Park CG, Yoo NJ and Lee JY . (2002). Cancer Lett., 178, 199–207.

  • Razin A and Cedar H . (1991). Microbil. Rev., 55, 451–458.

  • Shay JW and Bacchetti S . (1997). Eur. J. Cancer, 33, 787–791.

  • Smith JS, Brachmann CB, Celic I, Kenna MA, Muhammad S, Starai VJ, Avalos JL, Escalante-Semerena JC, Grubmeyer C, Wolberger C and Boeke JD . (2000). Proc. Natl. Acad. Sci. USA, 97, 6658–6663.

  • Sobin LH and Wittekind CH (ed). (1997). TNM Classification of Malignant Tumors 5th edn. Wiley-Liss, Inc: New York, pp. 59–62.

    Google Scholar 

  • Suzuki T, Yokozaki H, Kuniyasu H, Hayashi K, Naka K, Ono S, Ishikawa T, Tahara E and Yasui W . (2000). Int. J. Cancer, 88, 992–997.

    Article  CAS  Google Scholar 

  • Tahara H, Kuniyasu H, Yokosaki H, Yasui W, Shay JW, Ide T and Tahara E . (1995). Clin. Cancer Res., 1, 1245–1251.

  • Van Heek NT, Meeker AK, Kern SE, Yeo CJ, Lillemoe KD, Cameron JL, Offerhaus GL, Hicks JL, Wilentz RE, Goggins MG, De Marzo AM, Hruban RH and Maitra A . (2002). Am. J. Pathol., 161, 1541–1547.

  • Yanagihara K, Seyama T, Tsumuraya M, Kamada N and Yokoro K . (1991). Cancer Res., 51, 381–386.

  • Yaremko ML, Recant WM and Westbrook CA . (1995). Genes Chromosomes Cancer, 13, 186–191.

  • Yasui W, Tahara E, Tahara H, Fujimoto J, Naka K, Nakayama J, Ishikawa F, Ide T and Tahara E . (1999). Jpn. J. Cancer Res., 90, 589–595.

  • Yasui W, Tahara H, Tahara E, Fujimoto J, Nakayama J, Ishikawa F, Ide T and Tahara E . (1998). Jpn. J. Cancer Res., 89, 1099–1103.

  • Yasui W, Yokozaki H, Fujimoto J, Naka K, Kuniyasu H and Tahara E . (2000). J. Gastroenterol., 35, 111–115.

  • Yustein AS, Harper JC, Petroni GR, Cummings OW, Moskaluk CA and Powell SM . (1999). Cancer Res., 59, 1437–1441.

  • Zhou XZ and Lu KP . (2001). Cell, 107, 347–359.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Mr M Takatani and Ms M Ueda for their excellent technical assistance and advice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wataru Yasui.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kondo, T., Oue, N., Mitani, Y. et al. Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma. Oncogene 24, 157–164 (2005). https://doi.org/10.1038/sj.onc.1207832

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207832

Keywords

This article is cited by

Search

Quick links